News + Filings Transactions
|
RUDNICK SETH
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/29/2021 | G1 Therapeutics, Inc. | GTHX | Sale | Common Stock | 10k | $22.35 | $223.5k | | 06/29/2021 |
06/29/2021 | G1 Therapeutics, Inc. | GTHX | Exercise | Stock Option (Right to Buy) | 2k | $0.30 | $609.3 | | 06/29/2021 |
06/29/2021 | G1 Therapeutics, Inc. | GTHX | Exercise | Stock Options (Right to Buy) | 8k | $0.39 | $3.1k | | 06/29/2021 |
06/17/2021 | G1 Therapeutics, Inc. | GTHX | Grant | Common Stock | 4.4k | $0.00 | $0 | | 06/17/2021 |
06/17/2021 | G1 Therapeutics, Inc. | GTHX | Grant | Stock Options (Right to Buy) | 19.6k | $21.97 | $431.1k | | 06/17/2021 |
12/24/2020 | G1 Therapeutics, Inc. | GTHX | Sale | Common Stock | 924 | $20.10 | $18.6k | See Footnote | 12/24/2020 |
12/23/2020 | G1 Therapeutics, Inc. | GTHX | Sale | Common Stock | 13.1k | $20.18 | $264.8k | See Footnote | 12/22/2020 |
12/22/2020 | G1 Therapeutics, Inc. | GTHX | Sale | Common Stock | 19k | $20.33 | $385.7k | See Footnote | 12/22/2020 |
12/10/2020 | G1 Therapeutics, Inc. | GTHX | Sale | Common Stock | 546 | $20.00 | $10.9k | See Footnote | 12/08/2020 |
12/09/2020 | G1 Therapeutics, Inc. | GTHX | Sale | Common Stock | 5.8k | $20.32 | $117.3k | See Footnote | 12/08/2020 |
12/08/2020 | G1 Therapeutics, Inc. | GTHX | Sale | Common Stock | 13.2k | $20.19 | $265.7k | See Footnote | 12/08/2020 |
12/01/2020 | G1 Therapeutics, Inc. | GTHX | Sale | Common Stock | 520 | $20.09 | $10.4k | See Footnote | 12/01/2020 |
06/22/2020 | Liquidia Technologies Inc | LQDA | Grant | Non-Qualified Stock Option (right to buy) | 20k | $10.97 | $219.4k | | 06/22/2020 |
06/11/2020 | G1 Therapeutics, Inc. | GTHX | Grant | Stock Option (right to buy) | 20k | $17.59 | $351.8k | | 06/11/2020 |
08/29/2019 | Liquidia Technologies Inc | LQDA | Grant | Nonqualified Stock Option (right to buy) | 7.5k | $4.52 | $33.9k | | 08/29/2019 |
06/12/2019 | G1 Therapeutics, Inc. | GTHX | Grant | Stock Option (right to buy) | 20k | $18.47 | $369.4k | | 06/12/2019 |
12/04/2018 | G1 Therapeutics, Inc. | GTHX | Exercise | Stock Options (Right to Buy) | 9.4k | $0.39 | $3.7k | | 12/04/2018 |
12/04/2018 | G1 Therapeutics, Inc. | GTHX | Exercise | Stock Options (Right to Buy) | 607 | $0.39 | $236.7 | | 12/04/2018 |
12/04/2018 | G1 Therapeutics, Inc. | GTHX | Sale | Common Stock | 116 | $40.00 | $4.6k | | 12/04/2018 |
12/04/2018 | G1 Therapeutics, Inc. | GTHX | Sale | Common Stock | 9.9k | $39.31 | $388.5k | | 12/04/2018 |
11/05/2018 | G1 Therapeutics, Inc. | GTHX | Exercise | Stock Options (Right to Buy) | 10k | $0.39 | $3.9k | | 11/05/2018 |
11/05/2018 | G1 Therapeutics, Inc. | GTHX | Sale | Common Stock | 10k | $41.53 | $415.3k | | 11/05/2018 |
10/04/2018 | G1 Therapeutics, Inc. | GTHX | Sale | Common Stock | 8k | $49.65 | $398.2k | | 10/04/2018 |
10/04/2018 | G1 Therapeutics, Inc. | GTHX | Sale | Common Stock | 2k | $49.99 | $99k | | 10/04/2018 |
10/04/2018 | G1 Therapeutics, Inc. | GTHX | Exercise | Stock Options (Right to Buy) | 10k | $0.39 | $3.9k | | 10/04/2018 |
09/04/2018 | G1 Therapeutics, Inc. | GTHX | Exercise | Stock Options (Right to Buy) | 10k | $0.39 | $3.9k | | 09/04/2018 |
09/04/2018 | G1 Therapeutics, Inc. | GTHX | Sale | Common Stock | 500 | $60.31 | $30.2k | | 09/04/2018 |
09/04/2018 | G1 Therapeutics, Inc. | GTHX | Sale | Common Stock | 9.5k | $59.93 | $569.3k | | 09/04/2018 |
08/06/2018 | G1 Therapeutics, Inc. | GTHX | Sale | Common Stock | 10k | $50.69 | $506.9k | | 08/06/2018 |
08/06/2018 | G1 Therapeutics, Inc. | GTHX | Exercise | Stock Options (Right to Buy) | 10k | $0.39 | $3.9k | | 08/06/2018 |
06/07/2018 | G1 Therapeutics, Inc. | GTHX | Grant | Stock Option (right to buy) | 10k | $38.39 | $383.9k | | 06/07/2018 |
07/11/2017 | G1 Therapeutics, Inc. | GTHX | Grant | Stock Option (right to buy) | 20k | $15.55 | $311k | | 07/11/2017 |
05/22/2017 | G1 Therapeutics, Inc. | GTHX | Conversion | Common Stock | 2.8k | $0.00 | $0 | See Footnote | 05/22/2017 |
05/22/2017 | G1 Therapeutics, Inc. | GTHX | Conversion | Series B Preferred Stock | 8.3k | $0.00 | $0 | See Footnote | 05/22/2017 |
05/11/2017 | Aralez Pharmaceuticals Inc. | ARLZ | Grant | Director Stock Option (right to buy) | 15k | $1.56 | $23.4k | | 05/11/2017 |
|
|